Qualifacts Announces Carrie Lazorchak as New Chief Revenue Officer [Yahoo! Finance]
Definitive Healthcare Corp. (DH)
Company Research
Source: Yahoo! Finance
provider of end-to-end electronic health record (EHR) software and data solutions for behavioral health, rehabilitative, and human services organizations, today announced the appointment of Carrie Lazorchak as its new Chief Revenue Officer (CRO), effective immediately. Lazorchak brings over 20 years of experience driving growth and customer success in the SaaS industry. Throughout her career, she has held strategic leadership positions at various technology companies, including Definitive Healthcare and SimilarWeb. Most recently, she served as CRO at Definitive Healthcare, where she led commercial and customer success teams focused on delivering healthcare commercial insights that improve patient care. “We are thrilled to welcome Carrie to the Qualifacts team,” said Josh Schoeller, CEO of Qualifacts. “Her proven track record of building high-performing sales teams and her deep understanding of the SaaS business model will be instrumental in driving our continued growth and success
Show less
Read more
Impact Snapshot
Event Time:
DH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DH alerts
High impacting Definitive Healthcare Corp. news events
Weekly update
A roundup of the hottest topics
DH
News
- Definitive Healthcare Corp. (NASDAQ: DH) is now covered by analysts at BTIG Research. They set a "buy" rating and a $7.00 price target on the stock.MarketBeat
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of InvestorsBusiness Wire
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of InvestorsBusiness Wire
- Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire
- The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of InvestorsBusiness Wire
DH
Earnings
- 8/5/24 - Beat
DH
Sec Filings
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- DH's page on the SEC website